Mefloquine as a dual inhibitor of glioblastoma angiogenesis and glioblastoma via disrupting lysosomal function
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference26 articles.
1. Challenges in the treatment of glioblastoma: multisystem mechanisms of therapeutic resistance;Noch;World Neurosurg.,2018
2. Molecular targeted therapy of glioblastoma;Le Rhun;Canc. Treat Rev.,2019
3. Bevacizumab and glioblastoma: past, present, and future directions;Kim;Canc. J.,2018
4. The evolving role of antiangiogenic therapies in glioblastoma multiforme: current clinical significance and future potential;Anthony;Expet Opin. Invest. Drugs,2019
5. Mefloquine (WR 142,490) in the treatment of human malaria;Trenholme;Science,1975
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacology Progresses and Applications of Chloroquine in Cancer Therapy;International Journal of Nanomedicine;2024-07
2. Azithromycin inhibits glioblastoma angiogenesis in mice via inducing mitochondrial dysfunction and oxidative stress;Cancer Chemotherapy and Pharmacology;2023-07-24
3. The role of lysosomal peptidases in glioma immune escape: underlying mechanisms and therapeutic strategies;Frontiers in Immunology;2023-06-16
4. Autolysosomal activation combined with lysosomal destabilization efficiently targets myeloid leukemia cells for cell death;Frontiers in Oncology;2023-02-01
5. 4-(2-Butyl-6,7-dichloro-2-cyclopentyl-indan-1-on-5-yl) oxobutyric acid inhibits angiogenesis via modulation of vascular endothelial growth factor receptor 2 signaling pathway;Frontiers in Cardiovascular Medicine;2022-09-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3